Patent ID: 9649310
Date: 2017-05-16
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating Huntington's disease, Alzheimer's disease, Parkinson's disease, olivoponto cerebellar atrophy, non-Alzheimer's dementia, cerebral amyotrophic lateral sclerosis, cerebral ischemia, cerebral hypoxia, and epilepsy in a subject in need of such a treatment which method comprises administering to the subject a therapeutically effective amount of a compound of Formula I: or a pharmaceutically acceptable salt thereof wherein: R R R R R which is optionally substituted where m is 0 or 1 and n is 0 or 1, provided that at least one of m and n is 1, provided that when R where R 21 is halo and R 22 is hydrogen, halo, trifluoromethoxy, methyl, or isopropoxy.